Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells

Arthritis and Rheumatology

Volumn 66, Issue 5, 2014, Pages 1176-1184

  Moret, Frederique M ^a   Hack, Cornelis E ^a   Van Der Wurff Jacobs, Kim M G ^a   Radstake, Timothy R D J ^a   Lafeber, Floris P J G ^a   Van Roon, Joel A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD1C ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RHEUMATOID FACTOR; THYMIC STROMAL LYMPHOPOIETIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UPREGULATION;

ADULT; AGED; ANTIGENS, CD1; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; DENDRITIC CELLS; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYELOID CELLS; OSTEOARTHRITIS; RECEPTORS, CYTOKINE; SYNOVIAL FLUID;

EID: 84899729086     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38338     Document Type: Article

References (35)

1. Feldmann M, Brennan FM, Maini RN,. Rheumatoid arthritis. Cell 1996; 85: 307-10.
2. Morita Y, Yamamura M, Kawashima M, Harada S, Tsuji K, Shibuya K, et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1669-76.
3. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999; 42: 963-70.
4. Cornelissen F, van Hamburg JP, Lubberts E,. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis. Curr Opin Investig Drugs 2009; 10: 452-62.
5. Van Roon JA, van Roy JL, Duits A, Lafeber FP, Bijlsma JW,. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995; 54: 836-40.
6. Thomas R, Davis LS, Lipsky PE,. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994; 152: 2613-23.
7. Cavanagh LL, Boyce A, Smith L, Padmanabha J, Filgueira L, Pietschmann P, et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 2005; 7: R230-40.
8. Jongbloed SL, Lebre MC, Fraser AR, Gracie JA, Sturrock RD, Tak PP, et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther 2006; 8: R15.
9. Moret FM, Hack CE, van der Wurff-Jacobs KM, de Jager W, Radstake TR, Lafeber FP, et al. Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity. Arthritis Res Ther 2013; 15: R155.
10. Satpathy AT, Wu X, Albring JC, Murphy KM,. Re(de)fining the dendritic cell lineage. Nat Immunol 2012; 13: 1145-54.
11. Merad M, Sathe P, Helft J, Miller J, Mortha A,. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31: 563-604.
12. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-46.
13. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-80.
14. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-80.
15. Al-Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ,. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 2005; 202: 829-39.
16. Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6: 1047-53.
17. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000; 1: 59-64.
18. Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W, et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000; 192: 659-70.
19. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001; 167: 336-43.
20. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202: 1213-23.
21. Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 2004; 5: 426-34.
22. Hartgring SA, Willis CR, Dean CE Jr, Broere F, van Eden W, Bijlsma JW, et al. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis Rheum 2011; 63: 1878-87.
23. Koyama K, Ozawa T, Hatsushika K, Ando T, Takano S, Wako M, et al. A possible role for TSLP in inflammatory arthritis. Biochem Biophys Res Commun 2007; 357: 99-104.
24. Ozawa T, Koyama K, Ando T, Ohnuma Y, Hatsushika K, Ohba T, et al. Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-κB pathway and interferon-γ/dexamethasone. Mod Rheumatol 2007; 17: 459-63.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
26. Badot V, Durez P, Van den Eynde BJ, Nzeusseu-Toukap A, Houssiau FA, Lauwerys BR,. Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines. J Cell Mol Med 2011; 15: 2335-42.
27. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT,. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133-9.
28. Moret FM, Badot V, Lauwerys BR, van Roon JA,. Intraarticular soluble interleukin-7 [corrected] receptor levels are increased in patients with rheumatoid arthritis and correlate with local mediators of inflammation: comment on the article by Pickens et al [letter] [published erratum appears in Arthritis Rheum 2012;64:1302]. Arthritis Rheum 2012; 64: 594-5.
29. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A,. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-83.
30. Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 2010; 62: 2876-85.
31. - Tregs, regulate effector T cells using FasL. J Immunol 2007; 178: 4891-900.
32. + T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999; 11: 553-9.
33. Van Roon JA, Bijlsma JW, Lafeber FP,. Diversity of regulatory T cells to control arthritis. Best Pract Res Clin Rheumatol 2006; 20: 897-913.
34. h2 responses by inducing functional alteration of TSLP-activated dendritic cells. Int Immunol 2008; 20: 1321-9.
35. Tanaka J, Watanabe N, Kido M, Saga K, Akamatsu T, Nishio A, et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 2009; 39: 89-100.